JH
Janus Henderson Group Ltd. cut its CTNM stake below 5%
Janus Henderson Group Ltd. reported owning 4.6% of Contineum Therapeutics, Inc. (CTNM) (1,723,312 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G